| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 4 | |
| #3 | Canada | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | United States | 2 | |
| #6 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Pharmaceuticals | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Analysing materials | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Steroids |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wallace Thomas P | 11 |
| #2 | Harris William J | 11 |
| #3 | Carr Francis J | 11 |
| #4 | Old Lloyd J | 10 |
| #5 | Garin-Chesa Pilar | 10 |
| #6 | Rettig Wolfgang J | 7 |
| #7 | Calenoff Emanuel | 4 |
| #8 | Ditlow Charles C | 4 |
| #9 | Chen Francis W | 4 |
| #10 | Welt Sydney | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO9531546A1 | Recombinant human anti-varicella zoster virus antibodies | |
| CA2161438A1 | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |